Concepedia

Frederick R. Aronson

FR

23

Publications

1.5K

Citations

20

H-Index

1987

Active since

Affiliations

University of California, San Francisco(Current)

Tufts Medical Center

Loyola University Medical Center

Montefiore Medical Center

City Of Hope National Medical Center

Frederick R. Aronson is an author at University of California, San Francisco specializing in medicine, immunology, and oncology.

Top concepts

Publications per year

1987–2007

23

Publications

23

Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.

David Parkinson, Jeff Abrams, Peter H. Wiernik et al. · Journal of Clinical Oncology · 1990 · 198 citations

, , +14

A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.

Geoffrey R. Weiss, Kim Margolin, Frederick R. Aronson et al. · Journal of Clinical Oncology · 1992 · 157 citations

IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells.

Olivia M. Martinez, Reta S. Gibbons, Marvin R. Garovoy et al. · The Journal of Immunology · 1990 · 150 citations · Full text

IL-2 stimulates the production of IL-1 <i>alpha</i> and IL-1 <i>beta</i> by human peripheral blood mononuclear cells.

Robert P. Numerof, Frederick R. Aronson, J W Mier · The Journal of Immunology · 1988 · 106 citations

IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury.

Frederick R. Aronson, Peter Libby, Eugene P. Brandon et al. · The Journal of Immunology · 1988 · 100 citations

, , +18

Rows per page

1–5 of 23